Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft
Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies
Sponsor: Bolton Medical
This NA trial investigates Thoracic Aortic Aneurysms and and Penetrating Atherosclerotic Ulcers and is currently completed. Bolton Medical leads this study, which shows 10 recorded versions since 2007 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Feb 2018 — Jun 2018 [monthly]
Completed NA
-
Oct 2017 — Feb 2018 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2 → NA
-
Feb 2017 — Oct 2017 [monthly]
Unknown Status PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE2
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bolton Medical
For direct contact, visit the study record on ClinicalTrials.gov .